|
Kim, if you contact Genentech they'll send you information on the studies that have been done looking at dosing interval for Herceptin. The ones they sent me are about weekly vs. q3weeks in metastatic disease. Not sure if they have them for adjuvant treatment, but try asking. They were very helpful, returning my email with a phone call and then sending the documents right away (email attachments). Just google Genentech and look for patient assistance or something like that, fill out a short form, and they'll help you.
Debbie L.
PS: does anyone know how to change the name (not the signature) that appears with your post? I don't like having my whole email address up there, but can't remember how that happened, and can't find options to change it.
|
Threaded Mode